Please use this identifier to cite or link to this item:
Title: Re-suturing after primary endoscopic sleeve gastroplasty (ESG) for obesity
Authors: Lopez-Nava, Gontrand
Asokkumar, Ravishankar
Negi, Anuradha
Normand, Enrique
Bautista Castaño, Inmaculada 
UNESCO Clasification: 32 Ciencias médicas
320503 Gastroenterología
3213 Cirugía
Keywords: Bariatric endoscopy
Endoscopic sleeve gastroplasty
Weight regain
Issue Date: 2021
Journal: Surgical Endoscopy 
Abstract: Introduction: Although primary endoscopic sleeve gastroplasty (P-ESG) is effective, some patients may require revision procedures to augment weight loss. We hypothesized that a non-surgical approach using redo ESG (R-ESG) might be a viable option in such patients. We aimed to assess the safety and efficacy of R-ESG following P-ESG to treat obesity. Methods: We reviewed the outcome of patients who underwent R-ESG at our unit. We classified them as weight loss failure (WF)—< 10% total body weight (TBWL) at 6-months; weight regain (WR)—lost ≥ 10% TBWL and regained 50% of the maximum weight loss at or after 1-year; weight plateau (WP)—lost ≥ 10% TBWL but could not lose further over 3-months. We analyzed the feasibility, safety, and evaluated the efficacy of R-ESG in each group. Results: Of the 482 patients who underwent P-ESG, 35 (7%) required R- ESG (WF-12, WR-12, WP-11). The mean age, weight, BMI (38.2 kg/m2), and the number of sutures used during P-ESG were similar between the groups. The nadir %TBWL was lowest in WF group compared to WR and WP (6.5% vs. 20% vs. 22.4%, p = 0.001). The mean BMI at R-ESG was 33.6 kg/m2. The time to R-ESG was longer in the WR group compared to WF and WP (22.3 vs. 13.4 vs. 13.7 months, p = 0.03). We placed a median of 3 (range 2–6) sutures. R-ESG was technically successful, and no serious complications occurred. All except two patients were discharged on the same day. The overall %TBWL achieved by R-ESG was significantly higher in WP (26%) as compared to WF (11.2%) and WR (12%), respectively (p = 0.001). Conclusion: The need for R-ESG after P-ESG is low. R-ESG is safe and induced weight loss in all patients. The maximum benefit was observed in WP.
ISSN: 0930-2794
DOI: 10.1007/s00464-020-07666-6
Source: Surgical Endoscopy [ISSN 0930-2794], n. 35, p. 2523–2530, (Junio 2021)
Appears in Collections:Artículos
Show full item record


checked on May 26, 2024


checked on May 26, 2024

Page view(s)

checked on Jan 27, 2024

Google ScholarTM




Export metadata

Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.